$OPCH
Option Care Health, Inc.

2022 Q3 Form 10-Q Financial Statement

#000101473922000034 Filed on July 27, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $1.021B $980.8M $915.8M
YoY Change 14.46% 14.01% 20.62%
Cost Of Revenue $802.9M $763.9M $714.8M
YoY Change 16.54% 15.52% 20.39%
Gross Profit $218.0M $216.9M $200.9M
YoY Change 7.41% 9.01% 21.43%
Gross Profit Margin 21.35% 22.11% 21.94%
Selling, General & Admin $142.0M $141.8M $134.0M
YoY Change 5.48% 5.61% 11.6%
% of Gross Profit 65.14% 65.37% 66.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $15.27M $16.04M $14.72M
YoY Change -1.19% -3.5% -9.9%
% of Gross Profit 7.0% 7.39% 7.33%
Operating Expenses $157.3M $157.8M $148.7M
YoY Change 4.8% 4.61% 9.03%
Operating Profit $60.72M $59.08M $52.25M
YoY Change 14.82% 22.84% 79.57%
Interest Expense $14.00M $12.77M $12.25M
YoY Change -12.52% -25.94% -37.14%
% of Operating Profit 23.05% 21.61% 23.44%
Other Income/Expense, Net $3.888M $1.000K $2.000K
YoY Change 97100.0% -80.0% -100.02%
Pretax Income $52.08M $47.64M $41.27M
YoY Change 35.05% 46.37% -2706.95%
Income Tax $13.30M $13.70M $11.00M
% Of Pretax Income 25.54% 28.76% 26.66%
Net Earnings $38.82M $33.93M $30.28M
YoY Change 9.43% 6.64% -1158.2%
Net Earnings / Revenue 3.8% 3.46% 3.31%
Basic Earnings Per Share $0.21 $0.19 $0.17
Diluted Earnings Per Share $0.21 $0.19 $0.17
COMMON SHARES
Basic Shares Outstanding 181.9M shares 180.6M shares 180.0M shares
Diluted Shares Outstanding 183.0M shares 181.6M shares 181.7M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $255.5M $204.0M $145.6M
YoY Change 27.19% 29.53% 33.09%
Cash & Equivalents $255.5M $204.0M $145.6M
Short-Term Investments
Other Short-Term Assets $96.29M $78.56M $76.64M
YoY Change 48.48% 18.7% 32.37%
Inventory $236.0M $231.8M $217.2M
Prepaid Expenses
Receivables $364.2M $362.8M $366.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $952.0M $877.1M $805.7M
YoY Change 17.35% 19.21% 21.21%
LONG-TERM ASSETS
Property, Plant & Equipment $96.31M $105.2M $109.1M
YoY Change -9.81% -4.93% -6.23%
Goodwill $1.533B $1.512B $1.479B
YoY Change 7.31% 5.85% 3.49%
Intangibles
YoY Change
Long-Term Investments $21.70M $21.70M $21.40M
YoY Change 6.9% 9.05% 17.58%
Other Assets $47.02M $40.07M $37.75M
YoY Change 97.52% 71.18% 72.58%
Total Long-Term Assets $2.121B $2.109B $2.073B
YoY Change 7.41% 6.34% 4.9%
TOTAL ASSETS
Total Short-Term Assets $952.0M $877.1M $805.7M
Total Long-Term Assets $2.121B $2.109B $2.073B
Total Assets $3.073B $2.986B $2.878B
YoY Change 10.31% 9.83% 9.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $409.7M $380.5M $356.1M
YoY Change 28.62% 22.97% 22.4%
Accrued Expenses $171.1M $168.8M $146.0M
YoY Change 10.13% 22.05% 24.27%
Deferred Revenue
YoY Change
Short-Term Debt $177.1M $0.00 $0.00
YoY Change
Long-Term Debt Due $6.000M $6.000M $6.000M
YoY Change -49.04% -49.04% -49.04%
Total Short-Term Liabilities $586.8M $555.3M $508.1M
YoY Change 20.82% 20.85% 20.94%
LONG-TERM LIABILITIES
Long-Term Debt $1.059B $1.059B $1.059B
YoY Change -5.3% -5.4% -5.5%
Other Long-Term Liabilities $8.060M $13.45M $13.45M
YoY Change -10.18% 49.82% 49.82%
Total Long-Term Liabilities $1.149B $1.146B $1.148B
YoY Change -4.48% -4.74% -4.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $586.8M $555.3M $508.1M
Total Long-Term Liabilities $1.149B $1.146B $1.148B
Total Liabilities $1.736B $1.701B $1.657B
YoY Change 2.8% 2.33% 2.1%
SHAREHOLDERS EQUITY
Retained Earnings $142.9M $104.1M $70.14M
YoY Change -501.39% -246.42% -168.17%
Common Stock $1.172B $1.168B $1.143B
YoY Change 3.25% 3.1% 1.14%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.403M
YoY Change 0.0%
Treasury Stock Shares 383.7K shares
Shareholders Equity $1.337B $1.285B $1.222B
YoY Change
Total Liabilities & Shareholders Equity $3.073B $2.986B $2.878B
YoY Change 10.31% 9.83% 9.01%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $38.82M $33.93M $30.28M
YoY Change 9.43% 6.64% -1158.2%
Depreciation, Depletion And Amortization $15.27M $16.04M $14.72M
YoY Change -1.19% -3.5% -9.9%
Cash From Operating Activities $87.14M $104.3M $32.68M
YoY Change 70.11% 41.61% 77.81%
INVESTING ACTIVITIES
Capital Expenditures -$7.056M -$4.696M $5.359M
YoY Change 42.95% 26.65% 71.6%
Acquisitions
YoY Change
Other Investing Activities -$27.42M -$59.90M
YoY Change 217.72%
Cash From Investing Activities -$34.47M -$64.59M -$5.359M
YoY Change 598.42% 186.32% 71.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.242M 18.77M -$1.145M
YoY Change -58.03% -744.22% -77.81%
NET CHANGE
Cash From Operating Activities 87.14M 104.3M $32.68M
Cash From Investing Activities -34.47M -64.59M -$5.359M
Cash From Financing Activities -1.242M 18.77M -$1.145M
Net Change In Cash 51.42M 58.45M $26.18M
YoY Change 18.68% 21.36% 159.26%
FREE CASH FLOW
Cash From Operating Activities $87.14M $104.3M $32.68M
Capital Expenditures -$7.056M -$4.696M $5.359M
Free Cash Flow $94.19M $109.0M $27.32M
YoY Change 67.72% 40.89% 79.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001014739
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-11993
dei Entity Registrant Name
EntityRegistrantName
OPTION CARE HEALTH, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
05-0489664
dei Entity Address Address Line1
EntityAddressAddressLine1
3000 Lakeside Dr.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300N,
dei Entity Address City Or Town
EntityAddressCityOrTown
Bannockburn,
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60015
dei City Area Code
CityAreaCode
312
dei Local Phone Number
LocalPhoneNumber
940-2443
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
OPCH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
181861467 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
204046000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119423000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
362772000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
338242000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
231766000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
183095000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
78555000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
69496000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
877139000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
710256000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105210000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111535000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
73461000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
74777000 usd
CY2022Q2 bios Finite Lived Intangible Assets Net Excluding Customer Lists
FiniteLivedIntangibleAssetsNetExcludingCustomerLists
23161000 usd
CY2021Q4 bios Finite Lived Intangible Assets Net Excluding Customer Lists
FiniteLivedIntangibleAssetsNetExcludingCustomerLists
21433000 usd
CY2022Q2 bios Finite Lived Customer Lists Net
FiniteLivedCustomerListsNet
352368000 usd
CY2021Q4 bios Finite Lived Customer Lists Net
FiniteLivedCustomerListsNet
344587000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
1512246000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
1477564000 usd
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2256000 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
27033000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40071000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23733000 usd
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
2108773000 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2080662000 usd
CY2022Q2 us-gaap Assets
Assets
2985912000 usd
CY2021Q4 us-gaap Assets
Assets
2790918000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
380516000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
279246000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
58307000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
83503000 usd
CY2022Q2 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
91284000 usd
CY2021Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
71857000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19201000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19089000 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
555308000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
459695000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1059017000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1059900000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
73148000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74492000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13445000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20945000 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1145610000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1155337000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1700918000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1615032000 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12500000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12500000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
182213292 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
181829570 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180309637 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
179925915 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
18000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
18000 usd
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
383722 shares
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
383722 shares
CY2022Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2403000 usd
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2403000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1168052000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1138855000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
104071000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39867000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15256000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-451000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1284994000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1175886000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2985912000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2790918000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
980820000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
860272000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1896604000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1619509000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
763920000 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
661304000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1478768000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1255068000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
216900000 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
198968000 usd
us-gaap Gross Profit
GrossProfit
417836000 usd
us-gaap Gross Profit
GrossProfit
364441000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
141787000 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
134257000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
275756000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
254297000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16037000 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16619000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30759000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32958000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
157824000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
150876000 usd
us-gaap Operating Expenses
OperatingExpenses
306515000 usd
us-gaap Operating Expenses
OperatingExpenses
287255000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
59076000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
48092000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
111321000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
77186000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
12765000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
17236000 usd
us-gaap Interest Expense
InterestExpense
25011000 usd
us-gaap Interest Expense
InterestExpense
36717000 usd
CY2022Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1326000 usd
CY2021Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1686000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
2593000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
2891000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12396000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-11438000 usd
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-15545000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-22415000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-46222000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47638000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32547000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
88906000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30964000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13709000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
731000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24702000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2009000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
33929000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
31816000 usd
us-gaap Net Income Loss
NetIncomeLoss
64204000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8280000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
38566000 usd
us-gaap Net Income Loss
NetIncomeLoss
28955000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
756000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
4519000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
4637000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
4199000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
15707000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
8280000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4637000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4199000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15707000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36015000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
79911000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37235000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180621000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179843000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180293000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179826000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181618000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181037000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181176000 shares
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2512000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180975000 shares
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2593000 usd
us-gaap Net Income Loss
NetIncomeLoss
64204000 usd
us-gaap Net Income Loss
NetIncomeLoss
28955000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
33249000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
35705000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
9988000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5766000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
24777000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
907000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12403000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2117000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2891000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8576000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3730000 usd
CY2022Q2 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1000000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1000000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
506000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
261000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
22950000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
9866000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
48671000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14651000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5235000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4627000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
100924000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
26532000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-26384000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-907000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
18900000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
6425000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
11032000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
8277000 usd
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
10422000 usd
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-803000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
136954000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
92034000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10055000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6808000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
59897000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
18852000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69952000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25660000 usd
bios Proceeds From Payments For Stock Options Exercised Restricted Stock Vested And Tax Withholding
ProceedsFromPaymentsForStockOptionsExercisedRestrictedStockVestedAndTaxWithholding
523000 usd
bios Proceeds From Payments For Stock Options Exercised Restricted Stock Vested And Tax Withholding
ProceedsFromPaymentsForStockOptionsExercisedRestrictedStockVestedAndTaxWithholding
-78000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
20098000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
355200000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
3000000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
5888000 usd
us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
0 usd
us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
352009000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2880000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
2458000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17621000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8113000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
84623000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
58261000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119423000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99265000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
204046000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157526000 usd
us-gaap Interest Paid Net
InterestPaidNet
21793000 usd
us-gaap Interest Paid Net
InterestPaidNet
37405000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4966000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1168000 usd
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
12435000 usd
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
12909000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1015724000 usd
CY2021Q1 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
69000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1205000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2861000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4081000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1018080000 usd
CY2021Q2 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
9000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2525000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
31816000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4199000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1056611000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1175886000 usd
CY2022Q1 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
-355000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4178000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
30275000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11070000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1221764000 usd
CY2022Q2 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
-168000 usd
CY2022Q2 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
20098000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4398000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
33929000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4637000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1284994000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
21700000 usd
CY2022Q2 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
47000000 usd
CY2021Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
43000000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
20100000 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1300000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2600000 usd
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1700000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2900000 usd
CY2022Q2 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
661000 usd
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.288
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.278
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.288
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
980820000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
860272000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1896604000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1619509000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24700000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.278
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000 usd
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.022
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.065
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.022
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.065
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13000000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24700000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
33929000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
31816000 usd
us-gaap Net Income Loss
NetIncomeLoss
64204000 usd
us-gaap Net Income Loss
NetIncomeLoss
28955000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180621000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179843000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180293000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179826000 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
33929000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
31816000 usd
us-gaap Net Income Loss
NetIncomeLoss
64204000 usd
us-gaap Net Income Loss
NetIncomeLoss
28955000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180621000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179843000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180293000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179826000 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
997000 shares
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1194000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
883000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1149000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181618000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181037000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181176000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180975000 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
7400000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
14800000 usd
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
6900000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
14500000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M12D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0510
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
230357000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
14539000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
22190000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
16215000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
13388000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10416000 usd
CY2022Q2 bios Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
34835000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
111583000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
19234000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
92349000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8400000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5700000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
240562000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
135352000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
118822000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105210000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111535000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
8604000 usd
CY2021Q2 us-gaap Depreciation
Depreciation
8958000 usd
us-gaap Depreciation
Depreciation
17050000 usd
us-gaap Depreciation
Depreciation
17935000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
1477564000 usd
CY2022Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
936000 usd
CY2022Q1 us-gaap Goodwill
Goodwill
1478500000 usd
CY2022Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
33746000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
1512246000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2021Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
543618000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
530955000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
168089000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
164935000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
375529000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
366020000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8700000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16200000 usd
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17600000 usd
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1097000000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
8966000 usd
CY2022Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
23017000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
1065017000 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1059017000 usd
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1100000000 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
9605000 usd
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
24495000 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
1065900000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1059900000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
3000000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6000000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6000000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6000000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
6000000 usd
CY2022Q2 bios Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1070000000 usd
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1097000000 usd
CY2022Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1065017000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
5393000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
4199000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
20226000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
8280000 usd
CY2022Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
491000 usd
CY2021Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4247000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1184000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-8397000 usd
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
9101734 shares
CY2022Q2 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1000000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1000000 usd
CY2021Q2 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 usd
CY2021Q2 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 usd

Files In Submission

Name View Source Status
0001014739-22-000034-index-headers.html Edgar Link pending
0001014739-22-000034-index.html Edgar Link pending
0001014739-22-000034.txt Edgar Link pending
0001014739-22-000034-xbrl.zip Edgar Link pending
bios-20220630.htm Edgar Link pending
bios-20220630.xsd Edgar Link pending
bios-20220630_cal.xml Edgar Link unprocessable
bios-20220630_def.xml Edgar Link unprocessable
bios-20220630_g1.jpg Edgar Link pending
bios-20220630_htm.xml Edgar Link completed
bios-20220630_lab.xml Edgar Link unprocessable
bios-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
opch-ex311x20220630x10q.htm Edgar Link pending
opch-ex312x20220630x10q.htm Edgar Link pending
opch-ex321x20220630202210xq.htm Edgar Link pending
opch-ex322x20220630x10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending